|
O.D. Ostroumova, S.V. Litvinova, A.I. Kochetkov, N.A. Plotnikova, M.V. Klepikova, S.S. Eremina, S.V. Cheremushkin
Nonalcoholic fatty liver disease combined with dyslipidemia: the role of ursodeoxycholic acid in complex therapy
|
№1 / 2025
|
|
L.V. Tarasova, Yu.V. Tsyganova, I.Yu. Filippov
The role of essential phospholipids in the complex therapy of non-alcoholic fatty liver disease: a case-control study
|
№1 / 2025
|
|
N.V. Sturov, S.V. Popov, V.A. Zhukov, T.V. Lyapunova, I.V. Zelensky
Intestinal microbiota in patients with uncomplicated lower urinary tract infection: an observational case-control study
|
№1 / 2025
|
|
S.A. Derbeneva, S.V. Shmeleva, S.B. Kachalov, L.V. Elgarova
Evaluation of the effectiveness of diet therapy enriched with insoluble dietary fibers in patients with hyperlipoproteinemia
|
№1 / 2025
|
|
E.Yu. Plotnikova, L.G. Vologzhanina, A.Z. Azanov, A.S. Sukhikh
Comorbidity of liver and biliary tract diseases
|
№1 / 2025
|
|
L.V. Tarasova, L.A. Porfiryeva, O.V. Dimitrieva, N.Yu. Kucherova
A clinical case of early coronary atherosclerosis complicated by acute myocardial infarction in a young man with unspecified familial hypercholesterolemia
|
№1 / 2025
|
|
N.V. Korneeva, N.N. Mislimova
Clinical example of successful escalation of lipid-lowering therapy taking into account modern drug capabilities
|
№1 / 2025
|
|
O.D. Ostroumova, S.V. Litvinova, N.A. Plotnikova, A.I. Kochetkov, A.V. Arablinsky, S.S. Eremina
Known and little-known facts about acetylsalicylic acid
|
№1 / 2025
|
|
E.V. Rebrova, E.V. Shikh
Assessment of the effect of minimum steady-state concentrations of angiotensin II receptor blockers on the dynamics of office blood pressure values in patients with newly diagnosed stage 1–2 arterial hypertension
|
№1 / 2025
|
|
S.V. Malchikova, N.Yu. Lobanova, E.N. Chicherina, N.S. Maksimchuk-Kolobova
Clinical and economic efficiency of the coronary calcium score assessment in choosing a primary prevention strategy
|
№1 / 2025
|
|
A.I. Kochetkov, A.V. Dubinina, N.E. Gavrilova, T.N. Korotkova, I.V. Vorozhko, A.V. Starodubova, K.B. Mirzaev, O.D. Ostroumova
The diagnostic value of determining fibrosis biomarkers in patients with atrial fibrillation and coronary artery disease
|
№1 / 2025
|
|
V.D. Zakiev
Anticoagulant therapy in elderly patients with atrial fibrillation and atrial flutter: the position of rivaroxaban
|
№1 / 2025
|
Русский
